Bil­lion­aire Be­zos, Arch car­ry a torch for ag­ing R&D, back $116M mega-round for Uni­ty

Ag­ing R&D is get­ting a big boost to­day.

Jeff Be­zos, Arch and oth­er in­vestors drawn to the field have put to­geth­er a $116 mil­lion mega-round to back Uni­ty Biotech­nol­o­gy, which is look­ing to make the leap in­to the clin­ic with new drugs that can se­lec­tive­ly sweep away senes­cent cells that clut­ter our bod­ies as we age.

Uni­ty is al­so get­ting a new CEO. Kei­th Leonard, who had run Kythera un­til Al­ler­gan $AGN bought it out late last year for $2.1 bil­lion, is tak­ing the helm as the found­ing chief Ned David steps in­to the pres­i­dent’s job, with a spe­cial fo­cus on build­ing the plat­form.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER